ADD THIS DRUG TO MY LIST

Select the drug indication to add to your list

ZERBAXA
Bacterial infections
Compare To Related Drugs
View/Edit/Compare Drugs In My List

Only 4 drugs may be compared at once

Drug Name:

ZERBAXA Rx

Generic Name and Formulations:
Ceftolozane, tazobactam; 1.5g/vial; pwd for IV infusion after reconstitution; preservative-free; contains sodium chloride 487mg/vial.

Company:
Merck & Co., Inc.

Therapeutic Use:

Indications for ZERBAXA:

Susceptible complicated intra-abdominal infections in combination with metronidazole and complicated urinary tract infections, including pyelonephritis.

Adult:

Give by IV infusion over 1 hour. ≥18yrs (CrCl >50mL/min): complicated intra-abdominal infections: usually 1.5g every 8hrs for 4–14 days with IV metronidazole 500mg every 8hrs; complicated urinary tract infections: 1.5g every 8hrs for 7 days. Renal impairment (CrCl 30–50mL/min): 750mg every 8hrs; (CrCl 15–29mL/min): 375mg every 8hrs; ESRD on hemodialysis: 750mg loading dose, followed by 150mg maintenance dose every 8hrs for remainder of treatment (give on dialysis days).

Children:

<18yrs: not established.

Contraindications:

Cephalosporin, penicillin, or other beta-lactam allergy.

Warnings/Precautions:

Discontinue if serious hypersensitivity reactions occur. Moderate or severe renal impairment; monitor renal function daily and adjust dose. Elderly. Pregnancy (Cat.B). Nursing mothers.

Pharmacological Class:

Cephalosporin + beta-lactamase inhibitor.

Adverse Reactions:

Nausea, diarrhea, headache, pyrexia, constipation, insomnia, vomiting; C. difficile-associated diarrhea, anaphylaxis.

Generic Availability:

NO

How Supplied:

Single-use vials—10

Sign Up for Free e-Newsletters